Filtered By:
Source: Neurology
Condition: Disability

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 221 results found since Jan 2013.

Ischemic Stroke And Cervical Artery Dissection. Risk Factors And Functional Outcome In a Single Tertiary Care Hospital: The Clinica Alemana Stroke Registry (RECCA), 1997-2003 (P3.111)
ConclusionsThe prognosis of ischemic stroke patients with cervical artery dissections is generally good. The only variable associated with a worse prognosis, was a high NIHSS at admission. This allows early identification of a group of patients who are at increased risk of significant disability at discharge.Disclosure: Dr. Diaz has nothing to disclose. Dr. Vicuña has nothing to disclose. Dr. Fernandez has nothing to disclose. Dr. Valenzuela has nothing to disclose. Dr. Lavados has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Diaz, V., Vicuna, M., Fernandez, J., Valenzuela, M., Lavados, P. Tags: Cerebrovascular Disease and Interventional Neurology: Large Vessel Nonatherosclerotic Arteriopathies Source Type: research

What's the True Definition of an Adverse Event? (P4.289)
Conclusion: Based on this review we thus provide a new and comprehensive definition of AEs as: injuries expected or unexpected caused by healthcare provider,or occurring due to systems failure which can result in a measurable disability, prolonged hospitalization/both or be asymptomatic and is not due natural progression of the disease.Disclosure: Dr. Govindarajan has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Govindarajan, R. Tags: Practice, Policy, and Ethics: Stroke, Critical Care, and Other Source Type: research

The Impact of a Stroke Prevention Clinic after Discharge for TIA/ Stroke: University Hospitals Case Medical Center Comprehensive Stroke Center Experience (P3.121)
Conclusions: The burden of risk factors in our patients was very high. Although patients reported uniform adherence to treatment, risk factor control to target was good for hypertension and atrial fibrillation and poor for smoking, diabetes and dyslipidemia. Despite high rates of insurance and established primary care, multiple interventions were performed during this visit, particularly in the more disabled. The post-discharge SPC visit augments primary care and offers an important opportunity to review and revise the care plan, assess patient adherence and control of risk factors to target.*Chart and Graph imaging to be ...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Shams, T., Vickers, K., Jung, R., Sila, C. Tags: Cerebrovascular Disease and Interventional Neurology: Primary and Comprehensive Stroke Centers Source Type: research

Helping Haiti: Addressing the Burden of Neurologic Disease (P4.292)
CONCLUSIONS: With this nationwide collaborative and interdisciplinary approach, we hope to have a dramatic impact on the perceptions and outcomes of neurologic disease and provide a continuous, but dynamic presence in Port au Prince, Haiti while training physicians, nurses, and other team members in global health perspectives.Disclosure: Dr. Santini has nothing to disclose. Dr. Alessi has received personal compensation for activities with CBS Radio, the National Football League Players Association, and Colonial Cooperative Care. Dr. Jones has nothing to disclose. Dr. Etienne has nothing to disclose. Dr. Hohler has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Santini, V., Alessi, A., Jones, E., Etienne, M., Hohler, A. Tags: Global Health and Infection Source Type: research

Validating an Electronic Method for Prospective Fall Counting in People with MS (P3.142)
CONCLUSIONS: These data suggest that a daily electronic fall survey is a valid method for prospectively assessing fall frequency in people with MS. Further study with larger samples is needed. Support by: Michelle Cameron was supported by a CDA-2 from the Veterans Affairs Rehabilitation Research Development Service. Disclosure: Dr. Downs has nothing to disclose. Dr. Murchison has received research support from National Institute for Neurological Disorders and Stroke. Dr. Mazumder has received research support from the Agency for Healthcare Research and Quality, and the 2012 Foundation of the Consortium of MS Center...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Downs, A., Murchison, C., Mazumder, R., Cameron, M. Tags: MS and CNS Inflammatory Disease: Tools for Clinical Assessment and Therapeutic Response Source Type: research

Video Tracking of Cancellation Is Sensitive to Acute Brain Impairment and Disability (P3.226)
CONCLUSIONS: Video tracking of search on cancellation offers a simple, inexpensive, non-intrusive method to assess executive control in a wide variety of brain-impaired patients and appears to tap cognitive functions important to functional recovery.Study Supported by: UAB Department of Physical Medicine and Rehabilitation Resident Scholarly Project ProgramDisclosure: Dr. Mullins has nothing to disclose. Dr. Mark has nothing to disclose. Dr. Woods has nothing to disclose. Dr. Banasiewicz has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Mullins, L., Mark, V., Woods, A., Banasiewicz, M. Tags: Aging, Dementia, and Cognitive and Behavioral Neurology: Executive Function Source Type: research

Treating Neglect by Body Movements: A Case Report and Follow-Up Study (P3.043)
DISCUSSION: Our initial neglect patient named left-sided objects better when cued to move midline structures to the left. If midline structures are represented more bilaterally in the brain, they may be less affected by body-centered "aiming" bias. Future research would examine whether cueing with the nose/tongue is selectively helpful for patients with more severe neglect or with "aiming" bias and limb akinesia.STUDY SUPPORTED BY: National Institutes of Health and Kessler Foundation.Disclosure: Dr. Chaudhari has nothing to disclose. Dr. Pigott has nothing to disclose. Dr. Chen has nothing to disclose. Dr. Barrett has rece...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Chaudhari, A., Pigott, K., Chen, P., Barrett, A. Tags: Neural Repair and Neuro-rehabilitation: Clinical Source Type: research

Functional Motor Recovery In Stroke Survivors - Determinants In A Stroke Unit in Sub-Saharan Africa. (P3.045)
CONCLUSIONS:Frequent and effective visits to the physical therapist and to wit attainment of good and functional motor recovery may be hampered by its financial burden in resource poor settings where health insurance scarcely existStudy Supported by:NONEDisclosure: Dr. Imarhiagbe has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Imarhiagbe, F. Tags: Neural Repair and Neuro-rehabilitation: Clinical Source Type: research

Intervention Stroke Assessment Scale for Eligibility in Endovascular Therapy (ISAS-ET) (P4.213)
Conclusion:In conclusion, the ISAS scoring system might help with the assessment of patient qualification for further endovascular treatment. Further prospective studies are warranted.Disclosure: Dr. Haitham has nothing to disclose. Dr. Bashir has nothing to disclose. Dr. Hussain has nothing to disclose. Dr. Misthal has nothing to disclose. Dr. Moussavi has nothing to disclose. Dr. Kirmani has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Haitham, D., Bashir, A., Hussain, M., Misthal, S., Moussavi, M., Kirmani, J. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Endovascular Source Type: research

Thrombolytic Treatment for Acute Ischemic Stroke Patients with History of Migraine Headaches (P4.223)
Conclusion: Patients with migraine headaches receiving IV rt-PA treatment for acute ischemic stroke appear to have a lower rates of death and disability most likely related to their decreased rates of intracerebral hemorrhage.Disclosure: Dr. Malik has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Nickles has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Malik, A., Adil, M., Chaudhry, S., Qureshi, A. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Thrombolysis Source Type: research

Motor Component of National Institute of Health Stroke Scale Effect on Functional Outcome and Mortality at Discharge in Patient Receiving Endovascular Therapy (P4.240)
CONCLUSIONS:In conclusion, admission motor grade may serve as a good predictor of disability and mortality in patients undergoing mechanical thrombectomy with acute ischemic stroke. Further validation by a prospective study with a larger sample size is warranted.Disclosure: Dr. Misthal has nothing to disclose. Dr. Haitham has nothing to disclose. Dr. Bashir has nothing to disclose. Dr. Hussain has nothing to disclose. Dr. Moussavi has nothing to disclose. Dr. Kirmani has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Misthal, S., Haitham, D., Bashir, A., Hussain, M., Moussavi, M., Kirmani, J. Tags: Cerebrovascular Disease and Interventional Neurology: Endovascular Neurology Source Type: research

An Updated Cost-Effectiveness Analysis (CEA) of r-tPA for Acute Ischemic Stroke (AIS) Treated Within 3 Hours of Symptom Onset (P4.243)
CONCLUSIONS: Economic analyses suggest that r-tPA is highly cost-effective in treatment of AIS across numerous efficacy, safety, and mortality estimates. Further research on differences in long-term mortality in disabled and non-disabled patients is needed.Study Supported by: Genentech Inc.Disclosure: Dr. Boudreau has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received research support from Genentech, Inc. Dr. Tayama has received personal compensation for activities with Genentech Inc. Dr. Tayam ho...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Boudreau, D., Guzauskas, G., Tayama, D., Fagan, S., Veenstra, D. Tags: Cerebrovascular Disease and Interventional Neurology: Endovascular Neurology Source Type: research

Etiologies of Neurologic Deterioration in the First 30 Days Following Ischemic Stroke (P3.091)
CONCLUSIONS: In the present study we found that Neurological worsening is not uncommon. There are various different etiologies and majorities of these can be controlled and treated with strict control and Close observation of these patients to prevent further worsening of Neurological status and ultimate disability.Disclosure: Dr. Ahmed has nothing to disclose. Dr. Hirni has nothing to disclose. Dr. Albadarin has nothing to disclose. Dr. Duggal has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Ahmed, I., Hirni, K., Albadarin, S., Duggal, N. Tags: Cerebrovascular Disease and Interventional Neurology: Clinical Management Source Type: research

Risk Factors for Ischemic Stroke Mortality (P3.093)
CONCLUSION: as expected age, severity of stroke, and consequently long length-of-stay, were predictors of bad outcome. But is noticeable that damage of two other vascular territories (CHD and CKD) is related to mortality in IS patients, reinforcing the importance of global vascular risk evaluation in population with atherosclerotic disease.Disclosure: Dr. Alonzo has nothing to disclose. Dr. Zurru has nothing to disclose. Dr. Brescacin has nothing to disclose. Dr. Luzzi has nothing to disclose. Dr. Camera has nothing to disclose. Dr. Waisman has nothing to disclose. Dr. Cristiano has received personal compensation for activ...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Alonzo, C., Zurru, M., Brescacin, L., Luzzi, A., Camera, L., Waisman, G., Cristiano, E. Tags: Cerebrovascular Disease and Interventional Neurology: Clinical Management Source Type: research

Is the Use of r-tPA in Mild Stroke Patients Cost-Effective? (P3.104)
CONCLUSIONS: Economic analyses based on preliminary clinical data suggest that r-tPA could be cost saving or highly cost-effective in the treatment of mild patients. Controlled clinical trials will be valuable in definitively establishing the clinical and economic value of r-tPA in mild stroke.Study Supported by: Genentech Inc.Disclosure: Dr. Guzauskas has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received research support from Genentech, Inc. Dr. Chen has received personal compensation for activities with Genentech, Inc. as an employee. Dr. Khatri's institution has received resea...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Guzauskas, G., Chen, E., Khatri, P., Sandercock, P., Tayama, D., Veenstra, D. Tags: Cerebrovascular Disease and Interventional Neurology: t-PA Source Type: research